PRMT5 methylation of the TMPRSS2:ERG fusion protein is commonly seen in prostate cancer (PC) and implicated in prostate tumor formation by inhibiting AR -dependent transcription [50]. This evidence concerns the gene ERG and prostate carcinoma.